117 related articles for article (PubMed ID: 22915487)
21. Antipsychotic polypharmacy increases metabolic dysregulation in female rats.
Boyda HN; Procyshyn RM; Tse L; Xu J; Jin CH; Wong D; Pang CC; Honer WG; Barr AM
Exp Clin Psychopharmacol; 2013 Apr; 21(2):164-71. PubMed ID: 23356730
[TBL] [Abstract][Full Text] [Related]
22. Chronical haloperidol and clozapine treatment in rats: differential RNA display analysis, behavioral studies and serum level determination.
Fischer V; Schmitt U; Weigmann H; Von Keller B; Reuss S; Hiemke C; Dahmen N
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1129-39. PubMed ID: 9829293
[TBL] [Abstract][Full Text] [Related]
23. Sex-dependent effects of long-term clozapine or haloperidol medication on red blood cells and liver iron metabolism in Sprague Dawley rats as a model of metabolic syndrome.
Bouvier ML; Fehsel K; Schmitt A; Meisenzahl-Lechner E; Gaebel W; von Wilmsdorff M
BMC Pharmacol Toxicol; 2022 Jan; 23(1):8. PubMed ID: 35033194
[TBL] [Abstract][Full Text] [Related]
24. Honey promotes lower weight gain, adiposity, and triglycerides than sucrose in rats.
Nemoseck TM; Carmody EG; Furchner-Evanson A; Gleason M; Li A; Potter H; Rezende LM; Lane KJ; Kern M
Nutr Res; 2011 Jan; 31(1):55-60. PubMed ID: 21310307
[TBL] [Abstract][Full Text] [Related]
25. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
[TBL] [Abstract][Full Text] [Related]
26. Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum.
Dlaboga D; Hajjhussein H; O'Donnell JM
Neuropharmacology; 2008 Mar; 54(4):745-54. PubMed ID: 18222493
[TBL] [Abstract][Full Text] [Related]
27. Dietary sardine protein lowers insulin resistance, leptin and TNF-α and beneficially affects adipose tissue oxidative stress in rats with fructose-induced metabolic syndrome.
Madani Z; Louchami K; Sener A; Malaisse WJ; Ait Yahia D
Int J Mol Med; 2012 Feb; 29(2):311-8. PubMed ID: 22085913
[TBL] [Abstract][Full Text] [Related]
28. Risperidone treatment increases CB1 receptor binding in rat brain.
Secher A; Husum H; Holst B; Egerod KL; Mellerup E
Neuroendocrinology; 2010; 91(2):155-68. PubMed ID: 19815998
[TBL] [Abstract][Full Text] [Related]
29. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats.
Ríos-Lugo MJ; Cano P; Jiménez-Ortega V; Fernández-Mateos MP; Scacchi PA; Cardinali DP; Esquifino AI
J Pineal Res; 2010 Nov; 49(4):342-8. PubMed ID: 20663045
[TBL] [Abstract][Full Text] [Related]
30. cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects.
Sondhi S; Castellano JM; Chong VZ; Rogoza RM; Skoblenick KJ; Dyck BA; Gabriele J; Thomas N; Ki K; Pristupa ZB; Singh AN; MacCrimmon D; Voruganti P; Foster J; Mishra RK
Pharmacogenomics J; 2006; 6(2):131-40. PubMed ID: 16402076
[TBL] [Abstract][Full Text] [Related]
31. S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol.
Millan MJ; Brocco M; Gobert A; Schreiber R; Dekeyne A
J Pharmacol Exp Ther; 1999 Mar; 288(3):1002-14. PubMed ID: 10027837
[TBL] [Abstract][Full Text] [Related]
32. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
J Pharmacol Exp Ther; 1993 Mar; 264(3):1262-7. PubMed ID: 8383744
[TBL] [Abstract][Full Text] [Related]
33. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys.
Wagner JD; Zhang L; Kavanagh K; Ward GM; Chin JE; Hadcock JR; Auerbach BJ; Harwood HJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903
[TBL] [Abstract][Full Text] [Related]
34. Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886.
Kusunoki M; Tsutsumi K; Sato D; Nakamura A; Habu S; Mori Y; Morishita M; Yonemoto T; Miyata T; Nakaya Y; Nakamura T
Eur J Pharmacol; 2011 Oct; 668(3):486-91. PubMed ID: 21835171
[TBL] [Abstract][Full Text] [Related]
35. Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses.
Melkersson KI; Dahl ML
Psychopharmacology (Berl); 2003 Nov; 170(2):157-66. PubMed ID: 12851739
[TBL] [Abstract][Full Text] [Related]
36. Serum glucose and lipid changes during the course of clozapine treatment: the effect of concurrent beta-adrenergic antagonist treatment.
Baymiller SP; Ball P; McMahon RP; Buchanan RW
Schizophr Res; 2003 Jan; 59(1):49-57. PubMed ID: 12413642
[TBL] [Abstract][Full Text] [Related]
37. Body weight and leptin plasma levels during treatment with antipsychotic drugs.
Kraus T; Haack M; Schuld A; Hinze-Selch D; Kühn M; Uhr M; Pollmächer T
Am J Psychiatry; 1999 Feb; 156(2):312-4. PubMed ID: 9989571
[TBL] [Abstract][Full Text] [Related]
38. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of acute administration of clozapine or haloperidol on local cerebral glucose utilization in the rat.
Colangelo V; Di Grezia R; Passarelli F; Musicco M; Pontieri FE; Orzi F
Brain Res; 1997 Sep; 768(1-2):273-8. PubMed ID: 9369325
[TBL] [Abstract][Full Text] [Related]
40. Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats.
De Santis M; Pan B; Lian J; Huang XF; Deng C
Pharmacol Biochem Behav; 2014 Sep; 124():167-73. PubMed ID: 24933333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
